In this edition:
Diagnostic accuracy of prostate mpMRI vs 18F-DCPyL PSMA PET/CT
Gut microbiota signatures are associated with prostate cancer risk
Abiraterone ± olaparib in first-line treatment of mCRPC (PROpel trial)
Use of 177Lu-PSMA-617 prior to prostatectomy (LuTectomy trial)
Biodegradable device for controlled release of cisplatin in bladder cancer
Adjuvant chemotherapy in patients with node-positive UTUC
Kidney-sparing surgery vs radical nephroureterectomy for UTUC
Clinical significance of tumour location for ureteroscopic tumour grading in UTUC
Benefit of lymph node dissection in cN+ patients with UTUC
First-line avelumab for advanced urothelial cancer in PD-L1+ve patients unfit for cisplatin
Please login below to download this issue (PDF)